Diseases [C] » Immune System Diseases [C20] » Hypersensitivity » Hypersensitivity, Immediate
Description
Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. MeSH
Hierarchy View
Subtype Terms (10)
Anaphylaxis
16 drugs (11 approved, 5 experimental)
Asthma, Aspirin-Induced
6 drugs (5 approved, 1 experimental)
Conjunctivitis, Allergic
79 drugs (46 approved, 33 experimental)
Dermatitis, Atopic
383 drugs (123 approved, 260 experimental)
Eosinophilic Esophagitis
44 drugs (29 approved, 15 experimental)
Food Hypersensitivity
45 drugs (16 approved, 29 experimental)
Respiratory Hypersensitivity
3 approved drugs
Urticaria
58 drugs (39 approved, 19 experimental)
Phase 4 Indicated Drugs (1)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (15)
Organization Involved with Phase 1 Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
